Sigrid E Sandner

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. doi request reprint Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation
    Sigrid E Sandner
    Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria Electronic address
    J Heart Lung Transplant 33:88-93. 2014
  2. doi request reprint Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    J Heart Lung Transplant 27:469-73. 2008
  3. doi request reprint Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    Artif Organs 32:819-22. 2008
  4. doi request reprint Renal function and outcome after continuous flow left ventricular assist device implantation
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    Ann Thorac Surg 87:1072-8. 2009
  5. doi request reprint Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    J Heart Lung Transplant 28:367-72. 2009
  6. ncbi request reprint Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation: a pilot study
    Hubert Hetz
    Department of Anesthesiology and General Intensive Care, Medical University of Vienna, Vienna, Austria
    Liver Transpl 12:1357-64. 2006
  7. pmc New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs
    Masayuki Sho
    Laboratory of Immunogenetics and Transplantation, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Ann Surg 236:667-75. 2002
  8. ncbi request reprint Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection
    Sigrid E Sandner
    Transplantation Research Center, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Transplant 5:31-9. 2005
  9. ncbi request reprint Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo
    Sigrid E Sandner
    Transplantation Research Center, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Immunol 174:3408-15. 2005

Collaborators

Detail Information

Publications9

  1. doi request reprint Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation
    Sigrid E Sandner
    Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria Electronic address
    J Heart Lung Transplant 33:88-93. 2014
    ..We evaluated the feasibility of low-molecular-weight heparin (LMWH) for initiation of anti-coagulation and transitioning to oral anti-coagulation after LVAD implantation...
  2. doi request reprint Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    J Heart Lung Transplant 27:469-73. 2008
    ..This study was designed to determine the effect of continuous vs pulsatile flow devices on renal function after left ventricular assist device (LVAD) implantation...
  3. doi request reprint Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    Artif Organs 32:819-22. 2008
    ..In two patients, pump thrombosis was suspected. There were two ischemic and no hemorrhagic strokes. The use of LMWH may provide a new anticoagulation treatment option in the immediate postoperative period after LVAD implantation...
  4. doi request reprint Renal function and outcome after continuous flow left ventricular assist device implantation
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    Ann Thorac Surg 87:1072-8. 2009
    ..Renal dysfunction as a risk factor with the use of left ventricular assist devices (LVAD) is controversial. We determined the effect of renal function on outcomes after continuous flow LVAD implantation...
  5. doi request reprint Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation
    Sigrid E Sandner
    Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    J Heart Lung Transplant 28:367-72. 2009
    ..The effect of age on outcomes after continuous-flow left ventricular assist device (LVAD) implantation as a bridge to transplantation (BTT) was determined...
  6. ncbi request reprint Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation: a pilot study
    Hubert Hetz
    Department of Anesthesiology and General Intensive Care, Medical University of Vienna, Vienna, Austria
    Liver Transpl 12:1357-64. 2006
    ..MARS treatment provides a safe approach to the treatment of EAD after OLT. On the basis of this pilot study, a multicenter randomized clinical trial that uses MARS treatment in EAD after OLT has been initiated...
  7. pmc New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs
    Masayuki Sho
    Laboratory of Immunogenetics and Transplantation, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Ann Surg 236:667-75. 2002
    ..To determine the precise in vivo interaction between T-cell costimulatory blockade and conventional immunosuppression in transplantation...
  8. ncbi request reprint Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection
    Sigrid E Sandner
    Transplantation Research Center, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Transplant 5:31-9. 2005
    ....
  9. ncbi request reprint Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo
    Sigrid E Sandner
    Transplantation Research Center, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Immunol 174:3408-15. 2005
    ..These data demonstrate a critical role for the PD-1 pathway, particularly PD-1/PD-L1 interactions, in the regulation of alloimmune responses in vivo...